14
NEWS
Our most ambitious
chapter yet!
Breakthrough T1D publishes 10-year strategy to
accelerate Type 1 diabetes care.
Breakthrough T1D, the
diabetes charity formerly
known as JDRF, has launched
an ambitious new 10-year
strategy aimed at driving significant
advancements in Type 1 diabetes
(T1D) research, treatment, and care.
This new roadmap outlines how
the charity plans to transform the
lives of everyone living with T1D,
offering hope for a future with more
effective treatment options and the
opportunity for people to choose the
care that works best for them.
T1D care is evolving rapidly, with
advances in disease-modifying and
cellular therapies poised to transform
treatment. Disease-modifying
therapies, such as teplizumab, now
have the potential to transform
the landscape of T1D treatment by
delaying the onset of symptomatic
disease and altering its course. At
the same time, improvements in
early detection are enabling timely
interventions, while wider access to
new technologies like hybrid closed
loop are improving day to day life by
bringing a degree of automation to
people's treatment.
Faster, bolder
Breakthrough T1D's new 10-year
strategy plans to build on this
progress by driving faster, bolder
research by investing in innovative
global research and advocating
for faster access to life-changing
technologies, expanding treatment
options, and ongoing support. The
strategy also stresses the charity's
intention to work hand-in-hand with
the T1D community, ensuring that
the voices and experiences of people
living with the condition shape every
aspect of research, policy, and care.
Karen Addington, CEO of
Breakthrough T1D says: "We're not
just aiming to improve treatment.
We're committed to radically
transforming the future of T1D care.
At the heart of our 10-year strategy is
a continued commitment to the T1D
community. By working closely with
people affected, we will ensure their
voices shape the future of research,
treatment, and care, giving hope
for a world where T1D is no longer
a daily struggle, but a condition we
can prevent, manage, and ultimately
cure."
By working closely
with people
affected, we will
ensure their
voices shape the
future of research,
treatment, and
care - CEO Karen
Addington
1 OUR 10-YEAR STRATEGIC VISION
breakthrought1d.org.uk
Our 10-year
strategic vision
Driving breakthroughs now and in the future
To achieve these ambitions,
Breakthrough T1D plans to deepen
its engagement with supporters,
partners, and the wider T1D
community to secure the critical
funding needed to fuel progress. This
means recruiting more supporters,
inspiring new advocates, and
creating stronger collaborations with
researchers, healthcare providers,
and industry leaders.
breakthrought1d.org.uk